Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma

Zhen Sun,Songlei Xue,Meiying Zhang,Hui Xu,Xuming Hu,Shihao Chen,Yangyang Liu,Mingzhou Guo,Hengmi Cui

DOI: https://doi.org/10.1038/s41388-020-01475-w

IF: 8.756

2020-09-25

Oncogene

Abstract:Abstract RNA methylation is an important epigenetic modification. Recent studies on RNA methylation mainly focus on the m 6 A modification of mRNA, but very little is known about the m 5 C modification. NSUN2 is an RNA methyltransferase responsible for the m 5 C modification of multiple RNAs. In this study, we knocked down the NSUN2 gene in HepG2 cells by CRISPR/Cas9 technology and performed high-throughput RNA-BisSeq. An important tumor-related lncRNA H19 was identified to be targeted by NSUN2. Studies have shown that the expression of H19 lncRNA is abnormally elevated and has a carcinogenic effect in many types of tumors. Our results demonstrated that m 5 C modification of H19 lncRNA can increase its stability. Interestingly, m 5 C-modified H19 lncRNA can be specifically bound by G3BP1, a well-known oncoprotein which further leads to MYC accumulation. This may be a novel mechanism by which lncRNA H19 exerts its oncogenic effect. Besides, both the m 5 C methylation level and the expression level of H19 lncRNA in hepatocellular carcinoma tissues were significantly higher than those in adjacent non-cancer tissues, which were closely associated with poor differentiation of hepatocellular carcinoma (HCC). In conclusion, we found that H19 RNA is a specific target for the NSUN2 modifier. The m 5 C-modified H19 lncRNA may promote the occurrence and development of tumors by recruiting the G3BP1 oncoprotein. Our findings may provide a potential target and biomarker for the diagnosis and treatment of HCC.

oncology,genetics & heredity,biochemistry & molecular biology,cell biology